Results 91 to 100 of about 258,414 (117)
Some of the next articles are maybe not open access.
Exploring the consistency of the SF-6Dv2 in a breast cancer population
Expert Review of Pharmacoeconomics & Outcomes Research, 2020Background: Short-Form Six-Dimension version 2 (SF-6Dv2) is a multi-attribute utility instrument that can be used in combination with the SF-36v2 (SF-6Dv2SF-36) or as an independent instrument in two forms: six questions (SF-6Dv2ind-6) and 10 questions (SF-6Dv2ind-10).
Hosein Ameri +2 more
openaire +2 more sources
Eliciting SF-6Dv2 health state utilities using an anchored best-worst scaling technique
Social Science & Medicine, 2021There is an increasing interest in using ordinal data collection methods, such as the best-worst scaling (BWS), to develop preference-based tariffs (value sets) for health-related quality of life instruments, yet the evidence on their performance is limited.
Jing Wu, Gang Chen, Ahmed MY Osman
exaly +3 more sources
SF‐6Dv2 preference value set for health utility in food allergy
Allergy, 2020AbstractBackgroundThe lack of a value set allowing the calculation of QALY is an important limitation when establishing the value of emerging therapies to treat food allergy. The aim of this study was to develop a Short‐Form Six‐Dimension version 2 (SF‐6Dv2) preference value set for the calculation of health utility from the Canadian food‐allergic ...
Élise Dufresne +6 more
openaire +2 more sources
Mapping the cancer-specific FACT-B onto the generic SF-6Dv2
Breast Cancer, 2020The health-related quality of life (HRQoL) data extracted from cancer-specific questionnaires are often non-preference based, while patient preference-based utility data are required for health economic evaluation. This study aimed to map Functional Assessment of Cancer Therapy-Breast (FACT-B) subscales onto the Short Form six Dimension as an ...
Azin, Nahvijou +5 more
openaire +2 more sources
Comparison of four approaches in eliciting health state utilities with SF-6Dv2
European Journal of Health EconomicsTo empirically compare four preference elicitation approaches, the discrete choice experiment with time (DCETTO), the Best-Worst Scaling with time (BWSTTO), DCETTO with BWSTTO (DCEBWS), and the Standard Gamble (SG) method, in valuing health states using the SF-6Dv2.A representative sample of the general population in Quebec, Canada, completed 6 SG ...
Thomas G. Poder, Hosein Ameri
exaly +3 more sources
Valuing the SF-6Dv2 in the capital of Iran using a discrete choice experiment with duration
Quality of Life ResearchThe second version of the Short-Form 6-Dimension (SF-6Dv2) classification system has recently been developed. The objective of this study was to develop a value set for SF-6Dv2 based on the societal preferences of a general population in the capital of Iran.A representative sample of the capital of Iran (n = 3061) was recruited using a stratified ...
Thomas G. Poder +2 more
exaly +3 more sources
Quebec Health-related Quality of Life Population Norms in Adults Using the SF-6Dv2
Medical Care, 2022Objective: The Short-Form 6-Dimension version 2 (SF-6Dv2) is the newest version of the Short-Form 6-Dimension (SF-6D) that is widely used to calculate quality-adjusted life-years (QALYs). The aim of this study was to produce Quebec population norms from the SF-6Dv2.
Thomas G, Poder, Nathalie, Carrier
openaire +2 more sources
2023
Abstract Background Hypertrophic obstructive cardiomyopathy (HOCM) is a serious and complex chronic disease severely affecting patients’ daily lives and health-related quality of life (HRQoL). The psychometric performance of generic preference-based instruments has not been compared in Chinese ...
Xiaoyu Wang +4 more
openaire +1 more source
Abstract Background Hypertrophic obstructive cardiomyopathy (HOCM) is a serious and complex chronic disease severely affecting patients’ daily lives and health-related quality of life (HRQoL). The psychometric performance of generic preference-based instruments has not been compared in Chinese ...
Xiaoyu Wang +4 more
openaire +1 more source
A considerable debate persists in the literature about whose preferences should be considered in the calculation of quality-adjusted life-years. Some suggest considering only the preferences of the general population, while others advocate for the consideration of those of patients or a combination of both.
Thomas G. Poder, Moustapha TOURÉ
exaly +3 more sources
Psychometric performance of EQ-5D-5L and SF-6Dv2 in cancer patients
Health Services and Outcomes Research MethodologyThomas G. Poder, Hosein Ameri
exaly +2 more sources

